Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Ranolazine on Cardiac Arrhythmias and Microvolt T- Wave Alternans in Patients With Significant Left Ventricular Dysfunction

NCT00998218 is registered in ClinicalTrials.gov with Aspirus Heart and Vascular Institute-Research and Education as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00998218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Ranolazine on Cardiac Arrhythmias and Microvolt T- Wave Alternans in Patients With Significant Left Ventricular Dysfunction
Lead sponsor
Aspirus Heart and Vascular Institute-Research and Education
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2010
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sudden cardiac death, ventricular arrythmias